₹8.89
(Market cap
₹67 Cr
Recently Viewed
Clear AllMarket cap
₹67 Cr
Revenue (TTM)
₹45 Cr
P/E Ratio
3.8
P/B Ratio
2.9
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹18 Cr
ROE
-30.1 %
ROCE
-30.1 %
Industry P/E
28.5
EV/EBITDA
24.4
Debt to Equity
0
Book Value
₹33.4
EPS
₹3.3
Face value
10
Shares outstanding
6,826,960
CFO
₹2.04 Cr
EBITDA
₹-3.79 Cr
Net Profit
₹-2.51 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Phaarmasia
| -13.2 | 14.4 | -24.3 | 249.4 | 57.6 | 29.6 | 11.5 |
|
BSE Healthcare
| -1.9 | -1.8 | -2.4 | 7.7 | 24.3 | 13.4 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Phaarmasia
| 139.9 | 26.5 | 41.4 | -15.7 | -8.9 | 125.7 | 5.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Phaarmasia
|
97.8 | 66.8 | 44.9 | 17.8 | 3.7 | 22.9 | 3.8 | 2.9 |
| 2,806.0 | 35,025.7 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.5 | 7.6 | |
| 8,299.0 | 20,728.8 | 2,177.5 | 200.9 | 11.3 | 26.5 | 103.2 | 24.9 | |
| 1,708.4 | 12,988.1 | 2,089.5 | 622.0 | 31.3 | 20.4 | 21.2 | 3.9 | |
| 1,371.4 | 18,984.5 | 3,078.2 | 469.4 | 26.4 | 14.9 | 44 | 5.2 | |
| 2,005.4 | 32,172.0 | 4,193.0 | 753.8 | 22.7 | 20.8 | 42.7 | 8.0 | |
| 4,868.6 | 22,257.6 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.1 | 5.6 | |
| 4,943.0 | 8,206.2 | 1,348.5 | 293.5 | 28.1 | 50.7 | 28 | 11.8 | |
| 420.1 | 8,212.5 | 1,432.0 | 149.0 | 19.1 | 7.9 | 54.7 | 3.3 | |
| 1,000.0 | 9,223.3 | 4,725.6 | 528.7 | 14.9 | 20.7 | 18 | 3.1 |
No Review & Analysis are available.
Phaarmasia Limited manufactures and sells pharmaceutical products in India and internationally. It offers cosmetics, toothpastes, and oral contraceptive pills. The company was incorporated in 1981 and is based in Hyderabad, India.
Incorporated
1981
Chairman
--
Managing Director
--
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Phaarmasia Ltd is ₹97.83 (BSE) as of 10-Apr-2026 IST. Phaarmasia Ltd has given a return of 57.58% in the last 3 years.
The P/E ratio of Phaarmasia Ltd is 3.76 times as on 10-Apr-2026, a 87 discount to its peers’ median range of 28.50 times.
The P/B ratio of Phaarmasia Ltd is 2.93 times as on 10-Apr-2026, a 37 discount to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
4.45
|
|
2024
|
0.00
|
3.28
|
|
2023
|
0.00
|
2.43
|
|
2022
|
0.00
|
2.70
|
|
2021
|
54.38
|
1.80
|
The 52-week high and low of Phaarmasia Ltd are Rs 131.75 and Rs 26.00 as of 11-Apr-2026.
Phaarmasia Ltd has a market capitalisation of ₹ 67 Cr as on 10-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Phaarmasia Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.